Best Practices: 2009 Call for Entries

Entry Submissions Closed

Dinner Program Agenda  |  Awards Reception & DinnerBio-IT World Conference & ExpoSponsorship 

Bio-IT World Best Practices 2009

Bio-IT World is accepting entries for its prestigious 2009 Best Practices Awards Program.  Established in 2003, the program recognizes teams for their novel and innovative uses of technology, business strategies, and solutions benefiting the biosciences' value chain–from basic research to clinical trials. 

Special thanks to our 2009 Sponsors:  

    Tessella_125

   Bluecarc Sponsors Best Practices 2009

Eli Lilly 125

Direct entries are encouraged as well as nominations from users and solution providers.  All entries are reviewed and the winners selected by a distinguished panel of experts from industry and academia.  Awards will be presented at a gala dinner to be held on April 28, 2009, in conjunction with the 2009 Bio-IT World Conference & Expo, World Trade Center in Boston, MA, USA.

Entry Categories:   Entries may be submitted in one of the following categories with appropriate topics including, but not limited to:

  • Basic Research & Biological Research: Disease pathway research, applied and basic research
  • Drug Discovery & Development: Compound-focused research, drug safety
  • Clinical Trials & Research: Trial design, eCTD 
  • Translational Medicine: Feedback loops, predictive technologies
  • Personalized Medicine: Responders/non-responders, biomarkers
  • IT & Informatics: LIMS, High Performance Computing, storage, data visualization, imaging technologies
  • Knowledge Management: Data mining, idea/expertise mining, text mining, collaboration, resource optimization
  • Health-IT: ePrescribing, RHIOs, EMR/PHR
  • Manufacturing & Bioprocessing: Mass production, continuous manufacturing

Take advantage of this opportunity to showcase your organization's efforts and talents, and contribute to the industry's broader knowledge base. 

EARLY BIRD DEADLINE (No Fee): December 22, 2008
FINAL DEADLINE FOR ENTRIES: January 21, 2009
EXTENDED AND FINAL DEADLINE FOR ENTRIES: February 15, 2009
 
— Learn more: Access the
 Instructions and Entry Form. —

Benefits of participation:

  • Gain Peer Recognition: Spotlight the talent of your team, and position your organization as a thought leader, among an elite group of life science professionals.
  • Heighten Visibility: Use creative positioning to add another layer of credibility in the industry.  Entries, nominees and especially winners receive recognition at the Gala Dinner, in widely-distributed press releases, in the Best Practices issue of Bio-IT World magazine, as well as continued converage on Bio-ITWorld.com and in the Best Practices Compendium of entries.
  • Leverage Exposure:  Showcase your expertise and unique solutions, and use the exposure as a conduit to valuable connections, investors, sales leads, job candidates, and other external audiences.

Bio-IT World July/August 2008“Bio-IT World salutes the winners of its 2008 Best Practices Awards program. Not only have they demonstrated impressive technical achievements as judged by their peers, but also they’ve demonstrated a commitment to advancing 'best practices' throughout the biomedical research and drug development community by their willingness to share information about the innovative tools they are using and explaining how they use them.” 
-Kevin Davies, editor-in-chief, Bio-IT World

Read Bio-IT World’s coverage of the past awards programs and events, including winner profiles, speaker highlights and much more.

Best Practices 2008  |  Best Practices 2005
Best Practices 2004  |  Best Practices 2003 

Sponsorship Opportunities
As a supporter, your sponsorship of the Best Practices Awards Program offers extensive exposure to Bio-ITWorld audiences, positions your company as a thought-leader in the life science market, and gives you preferred access to the best and brightest thinkers in the life science community. Support this worthwhile industry program through one of our many sponsorship packages.

2008 Participants:    
3M Terminology Consulting Services
Abbott Laboratories
Affinium Pharmaceuticals
Affymetrix
Agilent Technologies
Applied Biosystems
Applied Cytometry
AstraZeneca Discovery
AstraZeneca Pharmaceuticals
Bayer Schering Pharma
Biomedicum Helsinki
Christian-Albrechts-University
CLC bio
Cogenics
Collexis Holdings
CRIX International
Curis
Dana-Farber Cancer Institute
Dolcera
DOV Pharmaceutical
Eli Lilly & Company
Entelos
Erasmus MC-University
Eurofins AvTech Laboratories
Genentech
Genstruct
GlaxoSmithKline

H. Lee Moffitt Cancer Center
Helsinki University of Technology
InforSense
Insightful Corp.
Integromics
Interactive Supercomputing
IO Informatics Cogenics
Johnson & Johnson PRD
Johnson & Johnson PRD Early Development
King Saud University
Laboratoires Fournier
Laboratório de Imunopatologia Keizo Asami
LabVantage Solutions
Lincoln Technologies
Malaysia Genome Institute
MediciGlobal
Medidata Solutions
Medtronic
Memorial Sloan Kettering Cancer Center
Merck & Company
MIT Whitehead Bio-Imaging Institute
Multiple Myeloma Research Consortium
National Cancer Institute
National Institute of Neurological Disorders and Stroke
Nationales Referenzzentrum für Streptokokken
Naval Medical Research Center
Northwestern University

Octagon Research
Omnicare Clinical Research
Ortho Biotech Clinical Affairs
Perceptive Informatics
Pfizer
Phoenix Data Systems
Physicians Reference Laboratory
REGISTRAT
River Road Bio
SAFE-BioPharma Association
Sage-N Research
SAS
Silicon Graphics Inc.
Sirtris Pharmaceuticals
SkinGenix
Society for Clinical Data Management
Strand Life Sciences
TAKE Solutions
Tembit Software
TEMIS
The BioTeam
UCB Pharma SA
University of Chicago
University of Pittsburgh Cancer Institute
University of Washington
Wyeth Research
Xceleron

Subscriptions to Bio-IT World Magazine are complimentary for qualifying individuals.  Apply today.

 

 

 

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.